Literature DB >> 20110591

11C-PiB PET ABri imaging in Worster-Drought syndrome (familial British dementia): a case report.

Victor L Villemagne1, Kerryn Pike, Svetlana Pejoska, Alison Boyd, Margaret Power, Gareth Jones, Colin L Masters, Christopher C Rowe.   

Abstract

Brain amyloid imaging is becoming an essential tool for the pre-mortem evaluation of Alzheimer's disease (AD). This study explores the pattern of 11C-PiB retention in a subject with Worster-Drought syndrome (WDS). A 55 year-old male carrier of the WDS gene mutation with mild signs of ataxia and subtle cognitive impairment underwent MRI and 11C-PiB-PET studies.Brain PiB regional distribution was compared to those from cohorts of healthy controls and AD patients. While no significant cortical 11C-PiB retention was present, a high degree of cerebellar 11C-PiB retention was observed in a genetically confirmed carrier of the WDS gene. We speculate that the sparsity of ABri plaques in the neocortex together with its high deposition in the cerebellum, might explain the observed pattern of 11C-PiB retention.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20110591     DOI: 10.3233/JAD-2010-1241

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  5 in total

1.  Brain oligomeric β-amyloid but not total amyloid plaque burden correlates with neuronal loss and astrocyte inflammatory response in amyloid precursor protein/tau transgenic mice.

Authors:  Bibiana DaRocha-Souto; Thomas C Scotton; Mireia Coma; Alberto Serrano-Pozo; Tadafumi Hashimoto; Lidia Serenó; Marta Rodríguez; Belen Sánchez; Bradley T Hyman; Teresa Gómez-Isla
Journal:  J Neuropathol Exp Neurol       Date:  2011-05       Impact factor: 3.685

Review 2.  Development of positron emission tomography β-amyloid plaque imaging agents.

Authors:  Chester A Mathis; N Scott Mason; Brian J Lopresti; William E Klunk
Journal:  Semin Nucl Med       Date:  2012-11       Impact factor: 4.446

Review 3.  2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Jesse Cedarbaum; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; Johan Luthman; John C Morris; Ronald C Petersen; Andrew J Saykin; Leslie Shaw; Li Shen; Adam Schwarz; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2015-06       Impact factor: 21.566

4.  [(11)C]PiB PET in Gerstmann-Sträussler-Scheinker disease.

Authors:  Kacie D Deters; Shannon L Risacher; Karmen K Yoder; Adrian L Oblak; Frederick W Unverzagt; Jill R Murrell; Francine Epperson; Eileen F Tallman; Kimberly A Quaid; Martin R Farlow; Andrew J Saykin; Bernardino Ghetti
Journal:  Am J Nucl Med Mol Imaging       Date:  2016-01-28

5.  Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer's disease.

Authors:  Victor L Villemagne; William E Klunk; Chester A Mathis; Christopher C Rowe; David J Brooks; Bradley T Hyman; Milos D Ikonomovic; Kenji Ishii; Clifford R Jack; William J Jagust; Keith A Johnson; Robert A Koeppe; Val J Lowe; Colin L Masters; Thomas J Montine; John C Morris; Agneta Nordberg; Ronald C Petersen; Eric M Reiman; Dennis J Selkoe; Reisa A Sperling; Koen Van Laere; Michael W Weiner; Alexander Drzezga
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-02       Impact factor: 9.236

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.